PROW and IWHLDA present the GUIDE on:
CD142
Author: James H. Morrissey
Reviewer: Steven D. Carson
ALTERNATE NAMES FOR CD142
 
- F3 [HUGO gene name]
- coagulation Factor III
- thromboplastin
- tissue factor, TF
MAJOR LINKS FOR CD142
 
- NCBI LocusLink Record: 2152
- Mendelian Inheritance in Man (OMIM): 134390
- SwissProt annotated protein record: P13726
FUNCTION
BIOCHEMICAL ACTIVITY OF CD142
 
- The 1:1 complex of CD142 and factor VIIa is the enzyme that initiates the blood clotting cascade
- Factor VIIa, a serine protease, is the catalytic subunit, and CD142 is the essential regulatory subunit
- CD142 also binds zymogen factor VII, the inactive precursor form; once bound, a variety of serine proteases rapidly activate factor VII to VIIa via limited proteolysis
CELLULAR FUNCTION OF CD142
 
- Expression on cell surface confers a procoagulant phenotype
- There is an initial report that binding of factor VIIa to CD142 results in changes in intracellular calcium ion levels
DISEASE RELEVANCE OF CD142 AND FUNCTION OF CD142 IN INTACT ANIMAL
 
- CD142 is the major initiator of clotting in normal hemostasis and many (if not all) thrombotic diseases
- Gene knockout in mice is embryonically lethal and associated with severe bleeding and defects in cardiovascular development
- Antibodies to CD142 protect animals against lethality of septic shock
STRUCTURE
MOLECULAR FAMILY FOR CD142
 - Families in which CD142 is a member
- CD142-->serine protease cofactor
MOLECULAR STRUCTURE OF CD142
 
- Single chain, type I transmembrane protein (263 amino acids)
- Extracellular region (219 amino acids) composed of two fibronectin type III domains (related to cytokine receptors). X-ray crystal structure solved
- Transmembrane domain (23 amino acids)
- Short cytoplasmic region (21 amino acids)
MOLECULAR MASS OF CD142
 
CELL TYPE | MW UNREDUCED | MW REDUCED | Comment |
Many cell types |
45-47 kDa |
45-47 kDa |
|
POST-TRANSCRIPTIONAL MODIFICATION OF CD142
 
- Single 2.3 kb mRNA species in many cell types
- In some cell types (e.g. monocytes) there is an additional mRNA species in which the first intron has not been removed, but this is apparently not translated
- Half-life of mRNA is short (<2 hr) and variable
POST-TRANSLATIONAL MODIFICATION OF CD142
 
- Single-chain protein; no proteolytic cleavage required for activation
- Three N-linked carbohydrate chains (dispensable for function)
- Phosphorylated cytoplasmic region
- Cytoplasmic cysteine residue is thioester linked to a fatty acyl chain
MOLECULAR INTERACTIONS
PROTEINS AND DNA ELEMENTS WHICH REGULATE TRANSCRIPTION OF CD142
 
MOLECULE | COMMENT |
AP-1 |
|
c-Rel/p65 |
|
Egr-1 |
|
Sp1 |
|
Ets |
|
SUBSTRATES FOR CD142
 
MOLECULE | COMMENT |
Factor X |
Activated via limited proteolysis by the cell-surface complex of CD142 and factor VIIa |
Factor IX |
Activated via limited proteolysis by the cell-surface complex of CD142 and factor VIIa |
Factor VII |
Activated via limited proteolysis by the cell-surface complex of CD142 and factor VIIa |
ENZYMES WHICH MODIFY CD142
  - No information
LIGANDS FOR CD142 AND MOLECULES ASSOCIATED WITH CD142
 
MOLECULE | COMMENT |
Factor VIIa |
|
Factor Xa/TFPI |
Binds to (and inhibits) the complex of CD142 and factor VIIa |
EXPRESSION
MAIN CELLULAR EXPRESSION OF CD142
 
- Expressed at high levels in epidermal keratinocytes, glomerular epithelial cells (and various other epithelia), adventitial cells of blood vessels, astrocytes, myocardium, Schwann cells of peripheral nerves, and stromal cells of organs such as liver, pancreas, spleen, and thyroid
- Normally absent from all cells in direct contact with plasma
- CD 142 can be induced by various inflammatory mediators in monocytes and vascular endothelial cells
- In cultured fibroblasts, inducible by serum and cytokines
AUTHOR'S ADDITIONAL INSIGHTS ON CD142
 
- Recent reports have implicated CD142 as also playing roles in tumor metastasis, breast cancer/hyperplasia, and angiogenesis
REAGENTS
CD142-SPECIFIC MABS NEWLY ASSIGNED AT SIXTH INTERNATIONAL WORKSHOP
 
NAME(Workshop IDs) | SOURCE or REFERENCE | COMMENT |
MTFH-1 (E131) |
James H. Morrissey, Oklahoma City, USA |
|
TF9-5B7 (E132) |
Morrissey JH et al. 1988 |
|
TF9-10H10 (E133) |
Morrissey JH et al. 1988 |
|
HTF-K4 (E134) |
Shin Nakamura, Inuyama, Japan |
|
HTF-K14 (E135) |
Shin Nakamura, Inuyama, Japan |
|
HTF-K108 (E034, E136) |
Shin Nakamura, Inuyama, Japan |
|
HTF1-7B8 (E016) |
Carson SD et al. 1987 |
|
TF8-5G9 (E138) |
Morrissey JH et al. 1988 |
|
TF10-1D10 (E139) |
Thomas S. Edgington, La Jolla, USA |
|
III-D8 (E140) |
Albrecht S et al. 1992 |
|
V-D8 (E141) |
Albrecht S et al. 1992 |
|
VI-C7 (E032) |
Albrecht S et al. 1992 |
|
SELECTION OF OTHER CD142-SPECIFIC REFERENCE MAB
  - No information
SELECTED REFERENCES ON CD142
 REVIEWS
1. Carson SD,Brozna JP The role of tissue factor in the production of thrombin. Blood Coagul Fibrinolysis 1993 4:281 PubMed
2. Mackman N Regulation of the tissue factor gene. FASEB J 1995 9:883 PubMed
PRIMARY CITATIONS
3. Albrecht S,Luther T,Grossmann H,Flossel C,Kotzsch M,Muller M An ELISA for tissue factor using monoclonal antibodies. Blood Coagul Fibrinolysis 1992 3:263 PubMed
4. Carson SD,Ross SE,Bach R,Guha A An inhibitory monoclonal antibody against human tissue factor. Blood 1987 70:490 PubMed
5. Morrissey JH,Fair DS,Edgington TS Monoclonal antibody analysis of purified and cell-associated tissue factor. Thromb Res 1988 52:247 PubMed
WWW RESOURCES
* indicates ammended by reviewer, ** indicates added by reviewer
Portions copyright by Garland Press and by the International Workshops on Human Leukocyte Differentiation Antigens; used with permission
Modified 10/14/99 mpr@mail.nih.gov